Drug Type Small molecule drug |
Synonyms GST HG131 |
Target |
Mechanism HBsAg inhibitors(HBsAg inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H29NO7 |
InChIKeyPQMAMDUBYCMNAT-NRFANRHFSA-N |
CAS Registry2270215-69-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B, Chronic | Phase 2 | CN | 26 Dec 2023 |
Phase 1 | - | - | (single-ascending-dose) | ryvzfkbkeb(uemeofsheq) = gahheernfz rujzwgqxrw (tlcinudpjm ) View more | Positive | 17 May 2022 | |
(multiple-ascending-dose) | - |